Published in Immunotherapy Weekly, December 5th, 2007
"Seventy-nine percent immunized with attenuated P. berghei sporozoite (PbSPZ) (six...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.